NCT01125033
- Conditions
- Chronic Disease, Disease Attributes, Dyssomnias, +17 more
- Locations
-
- Shiraz University of Medical Sciences Shiraz, Fars, Iran
Clinical trial condition
Parasomnias
Explore clinical trials studying Parasomnias. Study availability and eligibility vary by location and protocol.
323 public trials
49 recruiting studies
Parasomnias trial results
NCT00344994
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Medical College of Georgia Augusta, Georgia, United States
NCT00627003
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
Not specified
Completed
Comparative Evaluation of Gabapentine and Occlusal Splint in the Management of Sleep Bruxism
NCT01255878
- Conditions
- Bruxism, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- Mashhad University Of Medical Sciences Mashhad, Razavi Khorasan Province, Iran
NCT01178229
- Conditions
- Airway Remodeling, Bruxism, Mental Disorders, +9 more
- Locations
-
- CES Sabaneta Physiotheray Center Sabaneta, Antioquia, Colombia
NCT00942253
- Conditions
- Behavior, Chronic Disease, Disease Attributes, +25 more
- Locations
-
- University Hospital of Larissa, Nephrology Clinic Larissa, Thessaly, Greece
NCT00557258
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Boehringer Ingelheim Investigational Site Aachen, Germany
- Boehringer Ingelheim Investigational Site Aalen, Germany
- Boehringer Ingelheim Investigational Site Ahlen, Germany
- Boehringer Ingelheim Investigational Site Altena, Germany
NCT00423540
- Conditions
- Deficiency Diseases, Magnesium Deficiency, Malnutrition, +15 more
- Locations
-
- Richmond Hospital Richmond, British Columbia, Canada
Completed
A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS
NCT00625547
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Pfizer Investigational Site Innsbruck, Austria
- Pfizer Investigational Site Vienna, Austria
- Pfizer Investigational Site Altötting, Germany
- Pfizer Investigational Site Aschaffenburg, Germany
NCT00001549
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Autonomic Nervous System Diseases, +31 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States